Proteomic analysis — the characterization of all the proteins present in a cell at a given time — has revealed that a misregulation in the development of neural progenitor cells (NPCs), which eventually give rise to different types of nerve cells, might be implicated in Rett syndrome.
News
The world’s biggest gathering of rare disease researchers, patient groups, pharmaceutical executives, and government officials is planned for April 10–12 in a Washington, D.C., suburb. Some 1,200 people have already registered to attend the World Orphan Drug Congress (WODC) USA 2019, set to take place at the Gaylord National Harbor…
Rettsyndrome.org is dedicated to funding research in every stage of development and every aspect of Rett syndrome — that’s the main message from a recent webinar hosted by Steve Kaminsky, PhD, the organization’s chief science officer. The webinar, along with other RettEd webcasts, can be found here.
Three-dimensional microbrains built in the lab using stem cells from Rett syndrome patients can become a new model to study the disease, neuroscientists say. This can help identify new therapeutic compounds to treat Rett syndrome and accelerate therapy discovery for other neurodevelopmental disorders. The study, “3-Dimensional Human Cortical Neural…
About 100 scientists, researchers, pharmaceutical executives, and others will converge on Austria’s capital city early next month for the 2nd International Congress on Advanced Treatments in Rare Diseases. The March 4-5 meeting, to take place at the Hilton Am Stadtpark Vienna, features 27 speakers on a variety of disorders…
The first evidence that selective attention — the ability to focus on or select an object in the environment — is compromised by Rett syndrome was presented in new research findings. The article, “Impaired Visual Search in Children with Rett Syndrome,” was published in…
Meeting basic daily tasks, from getting dressed to assuring good hygiene and medical care, are so time-consuming for teenagers and young adults with Rett syndrome that time for more social and interactive activities is scarce, a study based on diaries kept by family members and caregivers found. Its researchers propose…
Scores of events are afoot worldwide to mark Feb. 28, Rare Disease Day 2019. The activities aim to raise awareness about rare diseases and the millions of people — estimates run as high as 350 million — they are thought to impact. Across countries, patients, caregivers and advocates will paint faces, wear…
Patient enrollment is now complete for the pivotal STARS study investigating the safety, tolerability, and effectiveness of sarizotan in Rett syndrome patients with respiratory abnormalities, Newron Pharmaceuticals announced. Top line results from the Phase 2/3 clinical trial are expected in the last quarter of 2019. Sarizotan was developed…
The Rett Syndrome Research Trust (RSRT) has awarded $10 million to a host of top international researchers to help find a cure for the neurological disorder. The 2018 award is the organization’s largest since its founding in 2008. To date, RSRT has awarded some $57 million for research. The…
Recent Posts
- An eye-gaze device gave my late daughter a voice
- Pivotal trial tests new gene therapy approach for Rett syndrome
- Pivotal trial of Rett gene therapy TSHA-102 now underway, and recruiting
- FDA approves Daybue Stix, drug’s powdered formulation, for treating Rett
- My youngest daughter has now lived longer than her older sister did
- Severe epilepsy increases care needs for people with Rett
- Gene therapy NGN-401 leads to functional gains in Rett syndrome
- New study links Rett energy problems to specific gene mutations
- A Rett syndrome clinical trial was our way of paying it forward
- Partners to design AI-based gene editing therapies for Rett